# South Korea Percutaneous Coronary Intervention Market > South Korea Percutaneous Coronary Intervention Market Research Report By Product Type (Coronary Stents, Ballon Catheters, Coronary Guidewires, Guiding Catheters, Guiding Sheaths, Diagnostic Catheters, Crossing Catheters, Inflation Device, Guidance System, Peripheral Thrombectomy System, Embolic Protection System, Accessories), By Vascular Access (Radial, Femoral) and By End User (Hospitals Clinics, Ambulatory Surgical Centers, Others) -Forecast to 2035 - **Forecast Period:** 2025 - 2035 - **CAGR:** 10.58% - **2024:** $ 292.4 Million - **2025:** $ 323.34 Million - **2035:** $ 884.2 Million - **Key Players:** Abbott (US), Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), B. Braun (DE), Terumo (JP), Cardinal Health (US), Siemens Healthineers (DE), Philips (NL) **Report ID:** MRFR/HC/43693-HCR · **Pages:** 200 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** April 06, 2026 **URL:** https://www.marketresearchfuture.com/reports/south-korea-percutaneous-coronary-intervention-market-45373 --- ## Market Summary ## **South Korea Percutaneous Coronary Intervention Market Overview** As per MRFR analysis, the South Korea Percutaneous Coronary Intervention Market Size was estimated at 212.67 (USD Million) in 2023.The South Korea Percutaneous Coronary Intervention Market is expected to grow from 234.0(USD Million) in 2024 to 486.0 (USD Million) by 2035. The South Korea Percutaneous Coronary Intervention Market CAGR (growth rate) is expected to be around 6.87% during the forecast period (2025-2035). **Key South Korea Percutaneous Coronary Intervention Market Trends Highlighted** The market for percutaneous coronary intervention (PCI) in South Korea is heavily impacted by the rising incidence of cardiovascular illnesses, which are mostly caused by aging populations and changes in lifestyle. The government has taken the initiative to support early intervention techniques, advance treatment alternatives, and fortify the healthcare system. Initiatives promoting the use of PCI technology, which are essential in lowering the risk of serious cardiovascular events, demonstrate this focus on enhancing heart health. As patients and healthcare professionals look to shorten recovery periods and hospital stays, recent trends indicate an increasing demand for less invasive procedures. Manufacturers are being prompted by this change to innovate and create cutting-edge catheter-based devices that improve patient outcomes and procedural efficiency. Furthermore, the use of digital technology, like telemedicine, in follow-up care after PCI is becoming increasingly popular, which is indicative of a larger movement in healthcare delivery toward more patient-centered methods. There are a lot of opportunities in the South Korean PCI industry, especially in the creation and launch of specialty devices for patients with complicated coronary artery disease or diabetes. Furthermore, partnerships between healthcare organizations and device makers are growing in importance as a result of government investments in health technology, which makes it possible to introduce novel solutions. To guarantee a competent workforce prepared to manage the changing landscape of cardiovascular treatments, improved training programs for medical professionals on the newest PCI procedures are also essential. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **South Korea Percutaneous Coronary Intervention Market Drivers** **Increasing Prevalence of Cardiovascular Diseases** The South Korea Percutaneous Coronary Intervention Market is witnessing significant growth driven by the rising incidence of cardiovascular diseases (CVDs) in the region. According to the Korean Society of Cardiology, CVDs are responsible for approximately 30% of all deaths in South Korea, highlighting a critical public health issue. Furthermore, the number of patients diagnosed with ischemic heart disease has seen an annual increase of 4-5%, leading to a higher demand for advanced treatment options such as percutaneous coronary interventions (PCI). This surge in patient numbers is further supported by government initiatives aimed at reducing the mortality rates associated with CVDs, such as the National Cardiovascular Strategy, which was devised to improve the outcomes of cardiac patients and promote effective treatment modalities, thereby further augmenting the market growth for PCI services and devices in South Korea. **Technological Advancements in Interventional Cardiology** Technological advancements are playing a crucial role in the growth of the South Korea Percutaneous Coronary Intervention Market. Innovative devices and techniques, including drug-eluting stents and bioresorbable scaffolds, have significantly improved patient outcomes and reduced recovery times. The Ministry of Health and Welfare in South Korea has noted that the adoption of these new technologies has led to a 16% decrease in post-procedure complications, encouraging more cardiologists to opt for PCI procedures as a first-line treatment. As healthcare providers continue to integrate cutting-edge technologies into their practices, the demand for PCI is likely to rise, further propelling market expansion. **Aging Population Driving Increased PCI Procedures** The aging population in South Korea is another significant driver of growth in the South Korea Percutaneous Coronary Intervention Market. By 2030, it is projected that over 20% of the South Korean population will be aged 65 and older, leading to a higher prevalence of age-related cardiovascular conditions. The Korean Institute for Health and Social Affairs reported that individuals in this age group are twice as likely to experience coronary artery disease compared to younger demographics. As a result, the healthcare system is expected to see an increase in the demand for PCI procedures to address these health issues, thereby boosting market growth and promoting further investments in cardiovascular care. **South Korea Percutaneous Coronary Intervention Market Segment Insights** **Percutaneous Coronary Intervention Market Product Type Insights** The South Korea Percutaneous Coronary Intervention Market is a critical aspect of the country's healthcare industry, particularly in the context of cardiovascular diseases that significantly impact the population. The dynamic and diverse landscape of this market can be understood through its various product types, including the likes of Coronary Stents, Balloon Catheters, and a range of other specialized devices. Coronary Stents are pivotal as they provide structural support to keep arteries open following a PCI procedure, thereby reducing the risk of restenosis. The Balloon Catheters play a crucial role in the initial phase of angioplasty, facilitating the dilation of narrowed arteries, which is essential for enhancing blood flow. Additionally, Coronary Guidewires and Guiding Catheters are indispensable tools that assist interventional cardiologists in maneuvering within the vascular system, ensuring precision during procedures. The Guiding Sheaths are designed to allow for easier access while protecting the surrounding blood vessels, thus making PCI safer and more effective. Diagnostic Catheters are also vital as they enable healthcare professionals to assess the coronary arteries and identify blockages accurately, which is crucial for determining the appropriate intervention. Moreover, Crossing Catheters and Inflation Devices hold significant importance by aiding in the delivery of therapies and ensuring the balloon is inflated to the correct pressure for optimal results. The Guidance Systems are becoming increasingly sophisticated, providing real-time imaging and assistance which improves procedural outcomes dramatically. On the more advanced front, Peripheral Thrombectomy Systems and Embolic Protection Systems are essential in preventing complications such as thrombosis during interventions, underscoring their relevance in enhancing patient safety. Accessories, though often overlooked, are integral to the functionality of PCI procedures, offering necessary support and tools for clinicians throughout the process. The South Korea Percutaneous Coronary Intervention Market showcases growing innovations in product development, reflecting a broader trend of technological advancement in medical devices, especially towards minimally invasive solutions that promise reduced recovery times and improved patient outcomes. The aging population and rising prevalence of cardiovascular conditions in South Korea are driving an increased demand for these products, creating an expansive opportunity for growth within the market. Additionally, the focus by the government on healthcare improvements and investments in medical technologies is further propelling the advancements within this segment. Overall, each product type contributes to the comprehensive approach required to effectively address the challenges posed by coronary diseases in South Korea, which is reflected in the continued expansion and evolution of the South Korea Percutaneous Coronary Intervention Market. Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review **Percutaneous Coronary Intervention Market Vascular Access Insights** The Vascular Access segment in the South Korea Percutaneous Coronary Intervention Market plays a crucial role in facilitating effective and efficient procedures in the cardiovascular clinical setting. With advancements in technology, there has been an increasing preference for the radial access route, which is widely recognized for its reduced risk of complications compared to femoral access. The ability to provide a more comfortable experience for patients and lower recovery times has led to its growing adoption among healthcare providers in South Korea. On the other hand, femoral access continues to dominate certain clinical scenarios where larger sheath sizes are required, ensuring its relevance in complex procedures. The South Korean healthcare system is investing heavily in training and education around these techniques, which further supports the market's growth. The high prevalence of cardiovascular diseases in the region underscores the importance of improving vascular access strategies as a component of the overall treatment landscape. Market trends show a shift towards less invasive methods, aligning with the global push for improved patient outcomes and safety within the South Korea Percutaneous Coronary Intervention Market. **Percutaneous Coronary Intervention Market End User Insights** The South Korea Percutaneous Coronary Intervention Market is shaped significantly by its End User segment, which includes Hospitals, Clinics, Ambulatory Surgical Centers, and Others. In South Korea, hospital clinics are vital as they provide comprehensive cardiac care and advanced procedural capabilities required in percutaneous interventions. These facilities are typically well-equipped with the latest technologies and medical expertise, crucial in enhancing surgical outcomes. Ambulatory Surgical Centers emerge as a significant player, driven by the increasing preference for outpatient procedures that reduce hospital stays and facilitate faster recovery, ultimately reflecting a trend towards cost efficiency in healthcare delivery. Additionally, the 'Others' category encapsulates various healthcare frameworks catering to diverse patient needs, including specialty clinics and rehabilitation centers, emphasizing a growing inclination towards integrated healthcare solutions. Overall, the dynamics within the End User segment showcase a landscape that is increasingly aligned with patient-centric care approaches, contributing to the ongoing development of the South Korea Percutaneous Coronary Intervention Market. **South Korea Percutaneous Coronary Intervention Market Key Players and Competitive Insights** The South Korea Percutaneous Coronary Intervention Market is characterized by a dynamic landscape where various healthcare providers and medical device manufacturers compete to establish market presence and gain a competitive edge. The increase in cardiovascular diseases and the growing aging population have driven the demand for advanced interventional cardiology procedures, creating opportunities for companies to innovate and expand their offerings. As the healthcare system continues to evolve, strategic collaborations, technological advancements, and the introduction of new products play a pivotal role in shaping market competition. Companies in this domain are focusing on enhancing patient outcomes, improving procedural efficiency, and meeting regulatory standards to maintain their competitive advantage. Understanding the competitive dynamics within this market is essential for stakeholders aiming to navigate the complexities of evolving healthcare demands. Terumo Corporation holds a significant position in the South Korea Percutaneous Coronary Intervention Market, owing to its strong manufacturing capabilities and commitment to quality. The company is known for producing high-quality medical devices that are crucial for catheter-based interventions, including specialized guide wires, balloons, and stents tailored for cardiac procedures. Terumo Corporation's strengths lie in its robust research and development efforts, which enable continual innovation to meet the needs of healthcare professionals and patients alike. Furthermore, the company has established a solid distribution network across South Korea, enhancing its ability to deliver products efficiently to hospitals and clinics. Terumo Corporation's commitment to education and training for healthcare professionals further solidifies its reputation in the market, as it invests in initiatives that promote best practices in the use of its technology. Elekta is also a key player in the South Korea Percutaneous Coronary Intervention Market, although its focus primarily extends to innovative software solutions and advanced medical devices designed to aid in cancer treatment and other interventional procedures. The company provides an array of products that facilitate enhanced imaging and navigation capabilities, which are vital for precise interventions in the cardiovascular domain. With a strong market presence bolstered by partnerships and collaborations with local healthcare institutions, Elekta capitalizes on its expertise in the radiation oncology sector to expand its reach within the cardiology market. The company’s strengths lie in its commitment to research and development, which has led to several key innovations that support interventional cardiologists in their day-to-day practices. Elekta’s strategic approach to mergers and acquisitions also plays a vital role in augmenting its technological offerings, allowing it to integrate state-of-the-art solutions into its product line. This multifaceted strategy helps Elekta maintain a competitive edge while navigating the complexities of the South Korean market. **Key Companies in the South Korea Percutaneous Coronary Intervention Market Include** - Terumo Corporation - Elekta - Johnson and Johnson - Boston Scientific - Siemens Healthineers - CathRx - Stryker Corporation - B. Braun Melsungen - Asahi Intecc - Abbott Laboratories - Medtronic - C. R. Bard - Cardinal Health - AngioDynamics - Cook Medical **South Korea Percutaneous Coronary Intervention****Market****Developments** Recent developments in the South Korea Percutaneous Coronary Intervention (PCI) market showcase significant activity among leading players. Companies like Terumo Corporation and Boston Scientific are focusing on technological advancements to enhance patient outcomes, with new products emerging that facilitate safer procedures. In September 2023, Medtronic introduced an innovative stent that promises to reduce restenosis rates, marking a crucial step in PCI treatment. Current affairs indicate a growing demand for PCI procedures in South Korea due to an aging population and rising cardiovascular disease prevalence, driving market valuation upward. Asahi Intecc and Abbott Laboratories are expanding their portfolios to cater to this demand, significantly impacting market dynamics. In terms of mergers and acquisitions, Stryker Corporation announced the acquisition of CathRx in March 2023, aiming to enhance its product offerings in coronary intervention technologies. Such strategic moves illustrate the competitive landscape and the consolidation trend within the PCI sector. Over the past two years, regulatory support from the South Korean government has contributed positively to market expansion with initiatives promoting healthcare innovation. This landscape fosters collaboration among key players, including Elekta, Johnson Johnson, and B. Braun Melsungen, further shaping the competitive environment. **South Korea Percutaneous Coronary Intervention Market Segmentation Insights** - **Percutaneous Coronary Intervention Market****Product Type****Outlook** - Coronary Stents - Ballon Catheters - Coronary Guidewires - Guiding Catheters - Guiding Sheaths - Diagnostic Catheters - Crossing Catheters - Inflation Device - Guidance System - Peripheral Thrombectomy System - Embolic Protection System - Accessories - **Percutaneous Coronary Intervention Market****Vascular Access****Outlook** - Radial - Femoral - **Percutaneous Coronary Intervention Market****End User****Outlook** - Hospitals Clinics - Ambulatory Surgical Centers - Others ## Market Drivers ### Rising Aging Population The aging population in South Korea is a critical driver for the percutaneous coronary-intervention market. As individuals age, the incidence of cardiovascular diseases tends to increase, leading to a higher demand for interventional procedures. According to recent statistics, approximately 15% of the South Korean population is aged 65 and older, a figure projected to rise significantly in the coming years. This demographic shift necessitates advanced medical interventions, including percutaneous coronary interventions, to manage age-related cardiovascular conditions. The healthcare system is adapting to this trend by enhancing facilities and training healthcare professionals, thereby fostering growth in the percutaneous coronary-intervention market. Furthermore, the increasing life expectancy in South Korea, which stands at around 83 years, further emphasizes the need for effective cardiovascular treatments, positioning the market for substantial expansion. ### Innovative Medical Devices The introduction of innovative medical devices is reshaping the landscape of the percutaneous coronary-intervention market. Recent advancements in catheter technology, stent design, and imaging techniques have significantly improved procedural outcomes. For instance, bioresorbable stents and drug-eluting balloons are gaining traction, offering enhanced safety and efficacy. The South Korean market has witnessed a surge in the adoption of these cutting-edge devices, with a reported growth rate of 10% in the last year alone. This trend is likely to continue as healthcare providers seek to improve patient outcomes and reduce complications associated with traditional interventions. Additionally, the integration of digital health technologies, such as telemedicine and remote monitoring, is expected to further enhance the efficiency of percutaneous coronary interventions, making them more accessible to patients across the country. ### Increased Healthcare Expenditure The rising healthcare expenditure in South Korea is a significant driver for the percutaneous coronary-intervention market. The government has been investing heavily in healthcare infrastructure and services, with healthcare spending reaching approximately 8.1% of GDP in recent years. This investment has led to improved access to advanced medical technologies and treatments, including percutaneous coronary interventions. As hospitals and clinics upgrade their facilities and acquire state-of-the-art equipment, the demand for these procedures is likely to increase. Furthermore, the South Korean government has implemented various health policies aimed at promoting preventive care and early intervention, which could lead to a higher volume of patients seeking percutaneous coronary interventions. This trend suggests a robust growth trajectory for the market, driven by both public and private sector investments. ### Supportive Regulatory Environment The supportive regulatory environment in South Korea plays a crucial role in facilitating the growth of the percutaneous coronary-intervention market. The government has established streamlined processes for the approval of new medical devices and technologies, which encourages innovation and market entry. Regulatory bodies are actively working to ensure that new interventions meet safety and efficacy standards, thereby fostering confidence among healthcare providers and patients alike. Recent initiatives aimed at expediting the approval process for life-saving devices have resulted in a quicker introduction of advanced percutaneous coronary-intervention technologies to the market. This proactive approach not only enhances patient access to cutting-edge treatments but also stimulates competition among manufacturers, potentially leading to lower costs and improved options for healthcare providers. As a result, the regulatory landscape is likely to continue supporting the expansion of the percutaneous coronary-intervention market. ### Growing Awareness of Cardiovascular Health There is a notable increase in public awareness regarding cardiovascular health in South Korea, which serves as a vital driver for the percutaneous coronary-intervention market. Educational campaigns and health initiatives have been instrumental in informing the population about the risks associated with cardiovascular diseases and the importance of early detection and treatment. As a result, more individuals are seeking medical advice and intervention at earlier stages of their conditions. This heightened awareness is reflected in the rising number of diagnostic procedures and subsequent interventions, including percutaneous coronary interventions. Moreover, the collaboration between healthcare providers and community organizations to promote heart health is likely to sustain this trend, further propelling the market forward. The emphasis on preventive care and lifestyle modifications is expected to complement the demand for interventional procedures. ## Future Outlook The [Percutaneous Coronary Intervention Market](https://www.marketresearchfuture.com/reports/percutaneous-coronary-intervention-market-3166) in South Korea is projected to grow at 10.58% CAGR from 2025 to 2035, driven by technological advancements and increasing cardiovascular disease prevalence. **New opportunities:** - Development of advanced biodegradable stents for improved patient outcomes. - Integration of AI-driven analytics for personalized treatment plans. - Expansion of telehealth services for remote patient monitoring and follow-up. By 2035, the market is expected to achieve substantial growth, reflecting enhanced treatment options and patient accessibility. ## Segment Insights ### By Product Type: Coronary Stents (Largest) vs. Balloon Catheters (Fastest-Growing) The South Korea percutaneous coronary-intervention market showcases a diverse range of product types, with Coronary Stents occupying the largest share due to their essential role in treating coronary artery disease. Other significant segments include Balloon Catheters, which have gained traction for their dual functionality in lesion dilation and drug delivery, followed by a variety of guidewires and catheters that collectively enhance procedural success rates. Growth trends in this market are driven by advancements in technology and increasing healthcare expenditure. The rise in the prevalence of cardiovascular diseases and the aging population are key factors propelling demand. Additionally, innovations in minimally invasive procedures are fostering rapid growth, especially for Balloon Catheters, which are essential for modern interventional techniques and showcase a promising growth trajectory as hospitals adopt more advanced technologies. Coronary Stents (Dominant) vs. Balloon Catheters (Emerging) Coronary Stents have established themselves as the dominant product in the South Korea percutaneous coronary-intervention market, primarily due to their critical role in maintaining patency of coronary arteries post-intervention. Their reliability and effectiveness in preventing restenosis make them the go-to choice for interventional cardiologists. Conversely, Balloon Catheters are emerging with innovative designs that enhance their efficacy and safety, such as drug-coated options that improve healing and reduce complications. The increasing adoption of these devices in cardiac procedures signifies a shift towards enhanced performance, reflecting the evolving landscape of cardiovascular treatment. With ongoing technological advancements, both segments are set to play pivotal roles in improving patient outcomes. ### By Vascular Access: Radial (Largest) vs. Femoral (Fastest-Growing) In the South Korea percutaneous coronary-intervention market, the Vascular Access segment is primarily dominated by the Radial approach, which accounts for a substantial market share. The Radial method has gained approval among healthcare providers due to its favorable safety profile and reduced complication rates compared to the Femoral approach. Recently, there has been an observable shift, with increasing adoption of access methods reflecting evolving clinician preferences and patient considerations. The Femoral access is recognized as the fastest-growing segment, as it benefits from advancements in catheter technology and procedural efficiency, which enhance its appeal in complex cases. The growing prevalence of coronary artery disease also fuels demand for effective vascular access solutions. Continuous education and training of medical professionals further promote the adoption of Femoral procedures, leading to anticipated growth in this segment over the coming years. Vascular Access: Radial (Dominant) vs. Femoral (Emerging) The Radial access method is characterized by its minimally invasive nature, offering patients reduced pain and faster recovery times, making it the preferred choice among many cardiologists. With a strong foothold in the South Korea percutaneous coronary-intervention market, it is often associated with better patient outcomes and a lower rate of complications such as bleeding. In contrast, the Femoral access method, while traditionally the dominant choice, is now labeled as an emerging segment due to its rapid evolution. It offers deep vascular access and is suitable for patients requiring complex interventions. Advanced technologies have enhanced its safety and efficiency, allowing it to capture the interest of a growing number of practitioners, signaling an important shift in procedural preferences. ### By End User: Hospitals & Clinics (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing) In the South Korea percutaneous coronary-intervention market, Hospitals & Clinics dominate the end user segment, holding a significant share of the overall market due to their comprehensive facilities and access to advanced technology. Ambulatory Surgical Centers, while smaller in current market share, are rapidly gaining traction due to the increasing preference for outpatient procedures, which offer both cost and time efficiencies. Growth trends in this segment indicate an upward trajectory for Ambulatory Surgical Centers, driven by advancements in minimally invasive techniques and improved patient outcomes. As healthcare systems seek to optimize resources and reduce hospital stay durations, the shift towards outpatient care through these centers is becoming a compelling option. This trend is also supported by rising health-consciousness among patients and increasing regulatory support for outpatient services. Hospitals & Clinics (Dominant) vs. Ambulatory Surgical Centers (Emerging) Hospitals & Clinics remain the dominant players in the South Korea percutaneous coronary-intervention market, characterized by their capacity to deliver a wide range of cardiac services and treatments. These institutions are equipped with sophisticated infrastructure, enabling the latest procedural techniques and comprehensive patient care. On the other hand, Ambulatory Surgical Centers are emerging as a growing alternative, appealing to patients seeking less invasive procedures and shorter recovery times. They offer specialized services that cater to outpatient requirements, leading to an enhanced patient experience. As healthcare delivery models continue to evolve, both segments will play crucial roles, but the emerging trend points towards an increasing demand for services from Ambulatory Surgical Centers. ## Competitive Benchmarking The percutaneous coronary-intervention market in South Korea is characterized by a dynamic competitive landscape, driven by technological advancements and an increasing prevalence of cardiovascular diseases. Major players such as Abbott (US), Boston Scientific (US), and Medtronic (US) are at the forefront, focusing on innovation and strategic partnerships to enhance their market presence. These companies are not only investing in research and development to introduce cutting-edge products but are also exploring mergers and acquisitions to consolidate their positions. The collective strategies of these firms contribute to a competitive environment that is both robust and evolving, as they seek to address the growing demand for effective cardiovascular interventions.Key business tactics employed by these companies include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting influence over various segments. This fragmentation allows for a diverse range of products and services, catering to the specific needs of healthcare providers and patients alike. The strategic focus on regional expansion and tailored solutions is likely to enhance competitive dynamics, as companies strive to capture a larger share of the market. In October Abbott (US) announced the launch of its latest drug-eluting stent, which incorporates advanced polymer technology aimed at improving patient outcomes. This strategic move is significant as it not only reinforces Abbott's commitment to innovation but also positions the company to better compete against rivals in the rapidly evolving landscape of coronary interventions. The introduction of this product is expected to enhance Abbott's market share and strengthen its reputation as a leader in cardiovascular solutions. In September Boston Scientific (US) expanded its partnership with a leading South Korean hospital network to enhance the adoption of its latest coronary intervention technologies. This collaboration is indicative of Boston Scientific's strategy to deepen its market penetration through strategic alliances, which may facilitate access to a broader patient base and improve clinical outcomes. Such partnerships are likely to play a crucial role in shaping the competitive landscape, as they enable companies to leverage local expertise and resources. In August Medtronic (US) unveiled a new digital platform designed to streamline the workflow of interventional cardiologists, integrating AI-driven analytics to enhance procedural efficiency. This initiative reflects Medtronic's focus on digital transformation and the integration of technology into clinical practice. By prioritizing such innovations, Medtronic aims to differentiate itself in a competitive market, where the ability to provide comprehensive solutions is increasingly valued by healthcare providers. As of November current trends in the percutaneous coronary-intervention market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence. Strategic alliances are becoming more prevalent, as companies recognize the importance of collaboration in driving innovation and improving patient care. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on technological advancements, innovative solutions, and reliable supply chains. This shift underscores the necessity for companies to adapt and innovate continuously in order to maintain a competitive edge in the market. ## Recent News & Developments Recent developments in the South Korea Percutaneous Coronary Intervention Market (PCI) market showcase significant activity among leading players. Companies like Terumo Corporation and Boston Scientific are focusing on technological advancements to enhance patient outcomes, with new products emerging that facilitate safer procedures. In September 2023, Medtronic introduced an innovative stent that promises to reduce restenosis rates, marking a crucial step in PCI treatment. Current affairs indicate a growing demand for PCI procedures in South Korea due to an aging population and rising cardiovascular disease prevalence, driving market valuation upward. Asahi Intecc and Abbott Laboratories are expanding their portfolios to cater to this demand, significantly impacting market dynamics. In terms of mergers and acquisitions, Stryker Corporation announced the acquisition of CathRx in March 2023, aiming to enhance its product offerings in coronary intervention technologies. Such strategic moves illustrate the competitive landscape and the consolidation trend within the PCI sector. Over the past two years, regulatory support from the South Korean government has contributed positively to market expansion with initiatives promoting healthcare innovation. This landscape fosters collaboration among key players, including Elekta, Johnson Johnson, and B. Braun Melsungen, further shaping the competitive environment. ## Report Scope | MARKET SIZE 2024 | 292.4(USD Million) | | --- | --- | | MARKET SIZE 2025 | 323.34(USD Million) | | MARKET SIZE 2035 | 884.2(USD Million) | | COMPOUND ANNUAL GROWTH RATE (CAGR) | 10.58% (2025 - 2035) | | REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends | | BASE YEAR | 2024 | | Market Forecast Period | 2025 - 2035 | | Historical Data | 2019 - 2024 | | Market Forecast Units | USD Million | | Key Companies Profiled | Abbott (US), Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), B. Braun (DE), Terumo (JP), Cardinal Health (US), Siemens Healthineers (DE), Philips (NL) | | Segments Covered | Product Type, Vascular Access, End User | | Key Market Opportunities | Advancements in minimally invasive techniques enhance patient outcomes in the percutaneous coronary-intervention market. | | Key Market Dynamics | Technological advancements and regulatory changes drive growth in the percutaneous coronary-intervention market in South Korea. | | Countries Covered | South Korea | ## Frequently Asked Questions **Q: What is the current valuation of the South Korea percutaneous coronary-intervention market?** A: The market valuation was $292.4 Million in 2024. **Q: What is the projected market size for the South Korea percutaneous coronary-intervention market by 2035?** A: The market is projected to reach $884.2 Million by 2035. **Q: What is the expected CAGR for the South Korea percutaneous coronary-intervention market during the forecast period 2025 - 2035?** A: The expected CAGR is 10.58% during the forecast period 2025 - 2035. **Q: Which product segment holds the highest valuation in the South Korea percutaneous coronary-intervention market?** A: Coronary Stents hold the highest valuation, ranging from $70.0 Million to $210.0 Million. **Q: What are the projected valuations for Balloon Catheters in the South Korea percutaneous coronary-intervention market?** A: Balloon Catheters are projected to range from $50.0 Million to $150.0 Million. **Q: How do the vascular access segments compare in terms of valuation?** A: The Femoral segment is valued between $176.2 Million and $535.8 Million, while the Radial segment ranges from $116.2 Million to $348.4 Million. **Q: What is the market valuation for hospitals and clinics as end users in the South Korea percutaneous coronary-intervention market?** A: Hospitals and Clinics are valued between $175.44 Million and $525.12 Million. **Q: Which companies are considered key players in the South Korea percutaneous coronary-intervention market?** A: Key players include Abbott, Boston Scientific, Medtronic, Johnson & Johnson, and B. Braun. **Q: What is the valuation range for guiding catheters in the South Korea percutaneous coronary-intervention market?** A: Guiding Catheters are projected to range from $25.0 Million to $75.0 Million. **Q: What is the expected growth trend for the South Korea percutaneous coronary-intervention market in the coming years?** A: The market is expected to grow significantly, driven by advancements in technology and increasing demand for coronary interventions. --- *This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-percutaneous-coronary-intervention-market-45373*